Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)

NCT04787744 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04787744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04787744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)
Lead sponsor
VA Office of Research and Development
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 1, 2021
Completion date
March 30, 2029
Enrollment
464 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

de novo prostate cancer, metastatic prostate cancer, oligometastasis, oligorecurrence, prostate cancer, recurrent prostate cancer